EverCell Bio
EverCell Bio is a privately held biotechnology company founded in 2017 and based in Natick, Massachusetts, providing product testing and human cell and stem cell support services to life sciences customers.
- Company typePrivate
- Founded2017
- HeadquartersNatick, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What EverCell Bio does
EverCell Bio is a privately held biotechnology company founded in 2017 and headquartered in Natick, Massachusetts. According to available firmographic data, the company provides product testing, human cell, and stem cell support services, which positions it in the life sciences research tools and cell biology services segment. Its operational scale is small, with a reported headcount of 1 to 10 employees, suggesting a boutique or contract-services posture rather than a scaled platform business. Founder, president, and CEO Philip Manos is the only identified member of the leadership team in the input.
The company's public web presence is minimal: its website (evercellbio.com) currently displays a verification/loading interstitial and contains no substantive corporate, product, pricing, or customer information. No revenue figures, funding history, customer accounts, partnership announcements, certifications, regulatory actions, or product catalog details are disclosed in the available data. There is no evidence of proprietary technology, patented processes, AI/ML capabilities, or platform architecture in the input. Given the absence of detailed disclosures, the specific revenue model, target customer segments (e.g., academic, pharmaceutical, diagnostic), pricing mechanics, and scientific differentiation underlying the cell and stem cell services cannot be characterized from the available input. The lack of verifiable public footprint means any investment assessment must rely primarily on direct management outreach.
EverCell Bio firmographics
Firmographics- Name
- EverCell Bio
- Website
- https://evercellbio.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 1–10 employees
- Short description
- EverCell Bio is a privately held biotechnology company founded in 2017 and based in Natick, Massachusetts, providing product testing and human cell and stem cell support services to life sciences customers.
- Ownership category
- akta.pro rank
EverCell Bio industry classification
Industry- Product category
- Biotechnology Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
- akta.pro secondary industries
- Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
Keywords
Where EverCell Bio is headquartered
LocationHeadquarters
- HQ city
- Natick
- HQ country
- United States
- HQ region
- North America
Markets served
EverCell Bio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
EverCell Bio product offering
Product offeringCore offering
EverCell Bio is a biotechnology company that provides product testing services along with human cell and stem cell support services to clients. The firm operates as a small-scale research services provider focused on cell-based testing and biological support for external customers.
Differentiator
Problem solved
Functional benefit
Products and services
- Product Testing Services
- Human Cell Support Services
- Stem Cell Support Services
Companies that use EverCell Bio
Customer profileIdeal customer profiles1 record
EverCell Bio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
EverCell Bio competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Large CRO offering cell-based bioassays, potency testing, and QC release services across biologics and cell therapy; comparable because it provides the same analytical and product testing capabilities EverCell Bio targets.
- Eurofins Scientific: Global testing services group with bioassay, sterility, and cell-based testing capabilities serving biopharma; relevant as a scaled provider of the same product testing and analytical services.
- BioReliance (Merck KGaA): Provides biosafety, sterility, and cell-based testing services for biologics and cell therapy developers; directly comparable testing services portfolio for cell and stem cell-based products.
- Lonza Cell & Gene: Major CDMO with cell therapy manufacturing and associated analytical/release testing services; comparable as a one-stop provider of cell therapy process and product testing.
- Catalent: CDMO offering cell therapy development, manufacturing, and analytical testing services; comparable on cell-based product testing and process support.
- Bio-Techne: Life science tools provider with cell-based assay reagents and analytical solutions; relevant as a provider of tools and services that overlap with cell-based potency and bioassay work.
Direct peers
- Cell & Gene Therapy Catapult: Specialized cell and gene therapy development and testing services organization; comparable as a focused provider of analytical and product testing support for cell-based therapies.
Emerging players
- STEMCELL Technologies: Supplies cell culture, stem cell, and assay products with associated services; comparable on the stem cell and human cell handling/testing axis.
- AcceGen: Specialized provider of primary cells, cell-based assays, and related testing services; comparable as a smaller, focused cell-based testing and human cell services company.
Regional players
- iProcess Global Research: Specialized cell and gene therapy services and testing provider; comparable in the niche of cell-based product testing and analytical support.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
EverCell Bio social profiles
Digital presenceEverCell Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
EverCell Bio leadership team
Management profileNumber of profiles
Profiles1 record
EverCell Bio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EverCell Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EverCell Bio
What does EverCell Bio do?
EverCell Bio is a biotechnology company that provides product testing services along with human cell and stem cell support services to clients. The firm operates as a small-scale research services provider focused on cell-based testing and biological support for external customers.
When was EverCell Bio founded?
EverCell Bio was founded in 2017. It employs 1 to 10 people.
Where is EverCell Bio based?
EverCell Bio is headquartered in Natick, United States, in the North America region.
Who are EverCell Bio's main competitors?
Broad incumbents on record are Charles River Laboratories, Eurofins Scientific, BioReliance (Merck KGaA), Lonza Cell & Gene, Catalent and Bio-Techne. Cell & Gene Therapy Catapult is listed as a direct peer. Emerging players are STEMCELL Technologies and AcceGen. iProcess Global Research is listed as a regional player.
Does EverCell Bio have an API?
No public API is recorded for EverCell Bio.
What industry is EverCell Bio in?
EverCell Bio's product category is Biotechnology Services. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAGAF, Analytical Development & QC Testing (Release/Stability/Potency). Its NAICS code is 541380 and its SIC code is 8731.